Aspergillus flavus mycetoma and epidural abscess successfully treated with itraconazole

Journal of Medical and Veterinary Mycology

Volumn 34, Issue 2, 1996, Pages 133-137

  Witzig, R S ^a,c   Greer, D L ^b   Hyslop Jr , N E ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE;

ADULT; ARTICLE; ASPERGILLUS FLAVUS; CASE REPORT; DIABETES MELLITUS; EPIDURAL ABSCESS; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LAMINECTOMY; MYCETOMA; UNITED STATES;

EID: 79961142234     PISSN: 02681218     EISSN: None     Source Type: Journal    
DOI: 10.1080/02681219680000201     Document Type: Article

References (17)

1. Mahgoub ES. Agents of mycetoma. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 4th edn. New York: Churchill Livingstone, 1995: 2327-30.
2. Kwon-Chung KJ, Bennett JE. Medical Mycology. Philadelphia, PA: Lea & Febiger, 1992: 560-93.
3. Espinel-Ingroff A, Pfaller MA. Antifungal agents and susceptibility testing. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology, 6th edn. Washington, DC: ASM Press, 1995: 1405-14.
4. Andriole VT. Invasive aspergillosis: serological diagnosis. In: Schimpff SC, Klastersky J, eds. Infectious Complications in Bone Marrow Transplantation. (Recent Results in Cancer Research, vol. 132), Berlin: Springer, 1993: 117-25.
5. Sabetta JR, Miniter P, Andriole VT. The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen. J Infect Dis 1985; 152: 946-53.
6. Bennett JE. Aspergillus species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 4th edn, New York: Churchill Livingstone, 1995: 2306-11.
7. Rippon JW. Medical Mycology, 3rd edn. Philadelphia, PA: WB Saunders, 1988: 618-50.
8. Mahgoub ES. Can Aspergillus flavus cause maduromycetoma? Bull Soc Pathol Exot Filiales 1973; 66: 390-5.
9. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev Infect Dis 1990; 12: 1147-200.
10. New PFJ, Shoukimas GM. Thoracic spine and spinal cord. In: Stark DD, Bradley WG, eds. Magnetic Resonance Imaging. St Louis: C. V. Mosby, 1988: 632-59.
11. Sapico FL, Montgomerie JZ. Vertebral osteomyelitis. Infect Dis Clin North Am 1990; 4: 539-50.
12. Sharif HS, Clark DC, Aabed MY, et al. Mycetoma: comparison of MR imaging with CT. Radiology 1991; 178: 865-70.
13. De Beule K, de Doncker P, Cauwenbergh G, et al. The treatment of aspergillosis and aspergilloma with itraconazole: clinical results of an open international study (1982-1987). Mycoses 1988; 31: 476-85.
14. Denning DW, Tucker RM, Hanson LH, Stevens DA. Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis. J Am Acad Dermatol 1990; 23 (3 Pt 2): 602-7.
15. Dupont B. Itraconazole therapy in aspergillosis: study in 49 patients. J Am Acad Dermatol 1990; 23 (3 Pt 2): 607-14.
16. Viviani MA, Tortorano AM, Pagano A, et al. European experience with itraconazole in systemic mycoses. J Am Acad Dermatol 1990; 23 (3 Pt 2): 587-93.
17. Denning DW, Hanson LH, Perlman AM, Stevens DA. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. Diagn Microbiol Infect Dis 1992; 15: 21-34.